The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index
Launched by RAMBAM HEALTH CARE CAMPUS · Apr 30, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Background Normal amniotic fluid volume varies across gestation (Ounpraseuth 2017). Abnormal amniotic fluid volume has been associated with a variety of adverse pregnancy outcomes (Shrem 2016). In clinical practice, the amniotic fluid volume is a component of the biophysical profile which provides information on fetal well-being.
Transabdominal ultrasound is used to assess quantitatively the amniotic fluid volume, most commonly by either the Amniotic Fluid Index (AFI) or the Maximum Vertical Pocket (MVP) methods.
The value of the AFI method has been questioned in several studies, which ha...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women at term beyond 37 weeks' gestation
- • Presented to our hospital for their routine care or prior to induction of labor
- • Singleton pregnancy
- • Planned for vaginal delivery
- • Non-laboring women with non-engaged fetal presenting part
- Exclusion Criteria:
- • Pregnant women under 37 weeks' gestation
- • Planned cesarean deliveries
- • Laboring women with engaged fetal presenting part
- • Multiple gestation
Trial Officials
Roy Lauterbach, MD
Principal Investigator
Rambam Health Care Campus
About Rambam Health Care Campus
Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials